3. Biomedical Materials
One place, where the new face of a functional, nano-engineered
materials science should be felt most keenly, is in the hospital.
We have, since time immemorial, been able to do little better in
effecting mechanical repairs to the body than if it were an inanimate
machine. Thus, prostheses of wood or metal have evolved into robotic
limbs of immeasurable benefit to the recipient, but nonetheless
a tacit submission to the traditional idea that the ways and materials
of engineering have little or no overlap with those of biology.
This disjunction becomes all the more stark in the case of artificial
organs, and it is perhaps remarkable that a heart imitated by a
plastic air-blown pump, or a kidney by a plastic membrane filter,
does so well! Such synthetic devices are by no means crude in engineering
terms: the Jarvik-7 artificial heart, for example, has complex laminated
polymer walls designed to minimize an inflammatory response and
to incur low friction and wear as it inflates and deflates. This
device has been used to sustain many patients awaiting urgent cardiac
transplants. But nothing of the kind will suffice for long-term
use.
In biomedicine, "minimal visibility" of materials was long equated
with inertness: as long as a material in contact with the bloodstream
did not provoke an allergic, toxic or inflammatory response, it
was deemed adequate. But to an organism, utter passivity is not
at all the same as invisibility. An inert material is typically
regarded as a wound, triggering the creation of scar tissue at the
interface. To truly look like a biological material, an implant
must be active, capable of a kind of communication with the surrounding
cells. That is why, for example, artificial blood vessels made from
polymers such as polytetrafluoroethylene (in a porous form comparable
to the Goretex fabric) may be given a lining of the protein heparin,
which prevents blood clotting. The epithelial cells of real blood
vessels release heparin to combat thrombosis, and the same end is
served by immobilizing heparin at the surface of synthetic vessels.
The same broad principle is being employed in materials that simulate
bone. Here, one finds a tidy illustration of the many, sometimes
conflicting, demands placed on a biomedical material. Clearly a
bone replacement must be strong and lightweight. Metals such as
stainless steel and titanium have good fracture-resistance, but
are considerably denser than real bone. The material must also be
corrosion-resistant, and if, as in hip joints, it is liable to be
subjected to movement against another hard surface, wear resistance
is crucial. Flexibility similar to that of real bone is also an
important attribute. And if the material takes up too much stress
in its load-bearing capacity, it can induce dissolution and weakening
in surrounding bone.
Small wonder, then, that the best bone replacement materials are
composites that derive the right combination of properties from
several distinct substances: e.g., fiber-reinforced polymers. A
porous microstructure is important both mechanically, and to allow
ingrowth of new tissue, e.g., so that the implant can develop an
intimate interface with freshly grown bone. Natural coral has been
used as a master for making molds with the required porosity.
Yet even this falls short of providing a material that can bind
smoothly and securely to real bone, as an implant is commonly required
to do. Again, inertness is in this respect a hindrance, not a help.
The formation of fresh bone demands a surface that is conducive
to the bone-depositing osteoblast cells. Bioactive ceramics are
materials that actively encourage this regrowth. These "bioglasses"
are typically mixtures of silica with sodium, calcium and phosphorus
oxides, which appear to be capable of mimicking the behavior of
the calcium phosphate (hydroxyapatite) component of real bone. Osteoblasts
will create crystallites of a carbonate-containing variant of hydroxyapatite,
a precursor to the deposition of true bone, on the surface of the
bioactive ceramic, and this helps to weld together the new bone
and the implant. Composites of bioactive ceramics with metals or
polymers can achieve an attractive combination of stength, flexibility
and compatibility with natural tissue.
If even apparently "mechanical" biological structures like blood
vessels and bone display this complexity of interaction with the
surrounding tissue and fluid, what are the prospects for developing
materials systems that have a more active biological role, like
that of the liver, the cornea, the spinal cord or the brain? While
some organs have a function that one might hope to mimic crudely
in purely artificial devices, there are others whose job can, at
present, be conducted only by the living cells themselves. We simply
do not know how to make an artificial nerve cell or neuron that
interfaces seamlessly with the real thing.
Therefore, the ultimate in biomedical materials engineering is
to find ways of growing the biological tissue itself: to grow new
organs in culture, seeded by the cells of the intended recipient.
This is called tissue engineering.
The process, as yet still hypothetical, is something like the following.
Rather than having to await a suitable donor and then run the risk
of transplant rejection, a person suffering from kidney failure
has a smattering of cells removed from her kidney. These are scattered
within a porous polymer material shaped like a kidney, and the cells
are stimulated into growth by the right amounts of nutrients. Slowly
the cells multiply and colonize the scaffold, which is gradually
dissolved away as the tissue forms around it. The cells are provided
with the hormones that promote the formation of a network of blood
vessels, ensuring that the nutrient-bearing "blood" gets distributed
throughout. The final product is a fully grown kidney, complete
with blood supply, ready to be implanted in the patient and fully
compatible with her immune system.
Some researchers even speculate that, given an appropriately shaped
scaffold seeded with cells of the requisite tissue types, an entire
artificial arm could be grown in culture to replace one lost in
an industrial accident. Once grown, it is simply stitched into place.
Figure 3. Graftskin, Artificial Skin Grown from
Cultured Cells
on a Scaffold of Biodegradable Polymer
The key to these advances is a suitable polymer scaffold: the material
should be broken down slowly by the cells into non-toxic by-products.
A copolymer of lactic and glycolic acid is a favorite material (approved
by the US Food and Drugs Administration), which is degraded to carbon
dioxide. Liver cells have been cultured in such supports. The formation
of blood vessels (angiogenesis) can be encouraged by doping the
scaffold with the protein called the angiogenic growth factor, which
does just what the name implies. Similarly, bone growth in a biodegradable
scaffold may be stimulated using bone morphogenic protein.
Many organs are not, however, just a mass of cells. They might
contain several different tissue types interwoven in a complex geometry
that is essential to proper cell-to-cell communication. For example,
the hepatocyte cells of the liver are mixed in with tissue-forming
fibroblasts. Hepatocytes cultured in isolation do not function so
efficiently. The right blend might be achieved by growing the two
cell types on surfaces treated with a thin layer of cell-adhesion
molecules. Techniques of microlithography, discussed in Section
6, may be used to imprint a microscopically patterned film of adhesion
molecules on the surface, and hepatocytes will then stick only to
the patterned areas. Once growth is underway, the intervening spaces
can be made adhesive too, and fibroblasts deposited in these interstices.
Studies of this kind have shown that there is an optimal patterning
scale at which the hepatocytes function best.
Biomedical materials are therefore moving in two related directions.
The first is towards greater biological integrity: synthetic materials
are being developed for their ability to interact with cells in
beneficial ways, so that the interface of the natural and the artificial
is as inobtrusive as possible. The ultimate extension of this approach
is then to remove the interface altogether: to grow real biological
materials, assisted by supports and scaffolding that direct and
stimulate the growth before, in the ideal case, being destroyed
by the very tissues whose formation they have promoted.
next page...
|